Former CEO Lee Rudow Files Intent to Sell $6.3M in Transcat Stock
TRNS sits 70% above its 52-week low of $50.23 on light trading volume (0.2× avg).
Summary
Former CEO and current Executive Chairman Lee Rudow filed a Form 144 to sell $6.3 million in Transcat stock, a notable insider disposition following recent disclosures of material weaknesses in financial controls.
Key Events · Ownership and Investor Activity · TRNS
-
Former CEO Files Intent to Sell
Lee D. Rudow, former CEO and current Executive Chairman, filed a Form 144 to sell 74,715 shares of common stock.
-
Significant Transaction Value
The proposed sale has an approximate market value of $6,314,912.
-
Follows Recent Governance Concerns
This filing follows the company's recent 10-K disclosure of critical material weaknesses in internal financial controls.
Analysis · TRNS · Industrial Applications And Services
Lee D. Rudow, the former CEO and current Executive Chairman, has filed a Form 144 indicating his intent to sell over $6.3 million worth of Transcat common stock. This proposed sale represents a significant portion of the company's market capitalization and comes shortly after the company reported critical material weaknesses in internal financial controls in its recent 10-K. While the shares were acquired through equity compensation over many years, a sale of this magnitude by a key insider could be interpreted negatively by the market, especially given the recent governance concerns.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 40.7% of the 388 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.42%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TRNS was trading at $85.63 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $799.8M. The 52-week trading range was $50.23 to $91.45. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.